Plasmonic nanobubbles enhance efficacy and selectivity of chemotherapy against drug-resistant cancer cells

Advanced Materials

Volumn 24, Issue 28, 2012, Pages 3831-3837

  Lukianova Hleb, Ekaterina Y ^a   Ren, Xiaoyang ^b   Zasadzinski, Joseph A ^c   Wu, Xiangwei ^b   Lapotko, Dmitri O ^a  

^a RICE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c University of Minnesota   (United States)

Author keywords

cancer; Doxil; drug resistance; gold nanoparticles; laser; plasmonic nanobubbles

Indexed keywords

CANCER; DOXIL; DRUG RESISTANCE; GOLD NANOPARTICLES; NANOBUBBLES;

CELLS; CHEMOTHERAPY; DRUG DELIVERY; LASERS; PLASMONS;

DRUG DOSAGE;

ANTINEOPLASTIC AGENT; NANOPARTICLE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RESISTANCE; HUMAN; HYPERTHERMIC THERAPY; MICROBUBBLE; MOUTH TUMOR; MULTIMODALITY CANCER THERAPY; NANOMEDICINE; NANOTECHNOLOGY; SQUAMOUS CELL CARCINOMA; TOPICAL DRUG ADMINISTRATION; TUMOR CELL LINE;

ADMINISTRATION, TOPICAL; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; HUMANS; HYPERTHERMIA, INDUCED; MICROBUBBLES; MOUTH NEOPLASMS; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY;

EID: 84859224405     PISSN: 09359648     EISSN: 15214095     Source Type: Journal    
DOI: 10.1002/adma.201103550     Document Type: Article

References (48)

1. A. Jemal, R. Siegel, J. Xu, E. Ward, CA Cancer J. Clin. 2010, 60, 277.
2. T. J. Ow, J. N. Myers, Clin. Exp. Otorhinolaryngol. 2011, 4, 1.
3. a) K. Cho, X. Wang, S. Nie, Z. G. Chen, D. M. Shin, Clin. Cancer Res. 2008, 14, 1310
4. b) D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, R. Langer, Nat. Nanotechnol. 2007, 2, 751
5. c) H. Meng, M. Liong, T. Xia, Z. Li, Z. Ji, J. I. Zink, A. E. Nel, ACS Nano 2010, 4, 4539
6. d) X. J. Liang, H. Meng, Y. Wang, H. He, J. Meng, J. Lu, P. C. Wang, Y. Zhao, X. Gao, B. Sun, C. Chen, G. Xing, D. Shen, M. M. Gottesman, Y. Wu, J. J. Yin, L. Jia, Proc. Natl. Acad. Sci. USA 2010, 107, 7449.
7. a) W. Cai, T. Gao, H. Hong, J. Sun, Nanotechnol. Sci. Appl. 2008, 1, 17
8. b) E. Boisselier, D. Astruc, Chem. Soc. Rev. 2009, 38, 1759
9. c) K. Sokolov, M. Follen, J. Aaron, I. Pavlova, A. Malpica, R. Lotan, R. Richards-Kortum, Cancer Res. 2003, 63, 1999
10. d) C. M. Pitsillides, E. K. Joe, X. Wei, R. R. Anderson, C. P. Lin, Biophys. J. 2003, 84, 4023.
11. a) I. H. El-Sayed, X. Huang, M. A. El-Sayed, Nano Lett. 2005, 5, 829
12. b) C. Loo, A. Lowery, N. Halas, J. West, R. Drezek, Nano Lett. 2005, 5, 709
13. c) J. L. West, N. J. Halas, Annu. Rev. Biomed. Eng. 2003, 5, 285.
14. a) P. Cherukuri, E. S. Glazer, S. A. Curley, Adv. Drug. Deliv. Rev. 2010, 62, 339
15. b) L. C. Kennedy, L. R. Bickford, N. A. Lewinski, A. J. Coughlin, Y. Hu, E. S. Day, J. L. West, R. A. Drezek, Small 2011, 7, 169.
16. D. Lapotko, Opt. Express 2009, 17, 2538.
17. E. Lukianova-Hleb, D. O. Lapotko, Nano Lett. 2009, 9, 2160.
18. E. Y. Lukianova-Hleb, A. Belyanin, S. Kashinath, X. Wu, D. Lapotko, Biomaterials 2012, 33, 1821.
19. D. S. Wagner, N. A. Delk, E. Y. Lukianova-Hleb, J. H. Hafner, M. C. Farach-Carson, D. O. Lapotko, Biomaterials 2010, 31, 7567.
20. E. Y. Hleb, Ying Hu, R. A. Drezek, J. H. Hafner, D. O. Lapotko, Nanomedicine 2008, 3, 797.
21. E. Y. Lukianova-Hleb, A. P. Samaniego, J. Wen, L. S. Metelitsa, C. C. Chang, D. O. Lapotko, J. Control. Release 2011, 152, 286.
22. L. Anderson, E. Hansen, E. Y. Lukianova-Hleb, J. H. Hafner, D. O. Lapotko, J. Control. Release 2010, 144, 151.
23. G. B. Braun, A. Pallaoro, G. Wu, D. Missirlis, J. A. Zasadzinski, M. Tirrell, N. O. Reich, ACS Nano 2009, 3, 2007.
24. D. Lapotko, E. Lukianova, M. Potapnev, O. Aleinikova, A. Oraevsky, Cancer Lett 2006, 239, 36
25. E. Y. Lukianova-Hleb, Koneva II, A. O. Oginsky, S. La Francesca, D. O. Lapotko, J. Surg. Res. 2011, 166, e3.
26. E. Lukianova-Hleb, Y. Hu, L. Latterini, L. Tarpani, S. Lee, R. A. Drezek, J. H. Hafner, D. O. Lapotko, ACS Nano 2010, 4, 2109.
27. D. O. Lapotko, E. Y. Lukianova-Hleb, A. A. Oraevsky, Nanomedicine 2007, 2, 241.
28. A. Vogel, J. Noack, G. Huttman, G. Paltauf, Appl. Phys. B 2005, 81, 1015.
29. E. Y. Hleb, J. H. Hafner, J. N. Myers, E. Y. Hanna, B. C. Rostro, S. A. Zhdanok, D. O. Lapotko, Nanomedicine 2008, 3, 647
30. D. Lapotko, E. Lukianova, A. Oraevsky, Lasers Surg Med 2006, 38, 631.
31. R. Weissleder, Nat. Biotechnol. 2001, 19, 316.
32. L. Svaasand, Lasers Med. Sci. 1989, 4, 309.
33. Laser Institute of America. American national standard for safe use of lasers (ANSI Z136.1-2000) 2000.
34. a) M. Fechheimer, J. F. Boylan, S. Parker, J. E. Sisken, G. L. Patel, S. G. Zimmer, Proc. Natl. Acad. Sci. USA 1987, 84, 8463
35. b) P. Prentice, A. Cuschierp, K. Dholakia, M. Prausnitz, P. Campbell, Nat. Phys. 2005, 1, 107.
36. a) B. Hildebrandt, P. Wust, O. Ahlers, A. Dieing, G. Sreenivasa, T. Kerner, R. Felix, H. Riess, Crit. Rev. Oncol. Hematol. 2002, 43, 33
37. b) T. S. Herman, B. A. Teicher, M. Jochelson, J. Clark, G. Svensson, C. N. Coleman, Int. J. Hyperthermia 1988, 4, 143
38. c) C. D. Kowal, J. R. Bertino, Cancer Res. 1979, 39, 2285.
39. M. M. Gottesman, Cancer Res. 1993, 53, 747.
40. W. C. W. Chan, T. S. Hauck, T. L. Jennings, T. Yatsenko, J. C. Kumaradas, Adv. Mater. 2008, 20, 3832.
41. B. Fisher, P. Kraft, G. M. Hahn, R. L. Anderson, Cancer Res. 1992, 52, 2854.
42. a) M. Urano, Cancer Res. 1986, 46, 474
43. b) K. Rege, H. C. Huang, Y. Yang, A. Nanda, P. Koria, Nanomedicine 2011, 6, 459
44. c) J. R. Lepock, Int. J. Hyperthermia 2003, 19, 252.
45. a) G. H. Wu, A. Milkhailovsky, H. A. Khant, C. Fu, W. Chiu, J. A. Zasadzinski, J. Am. Chem. Soc. 2008, 130, 8175
46. b) L. Paasonen, T. Sipila, A. Subrizi, P. Laurinmaki, S. J. Butcher, M. Rappolt, A. Yaghmur, A. Urtti, M. Yliperttula, J. Control. Release 2010, 147, 136
47. c) D. Pissuwan, T. Niidome, M. B. Cortie, J. Control. Release 2011, 149, 65
48. d) G. Qin, Z. Li, R. Xia, F. Li, B. E. O'Neill, J. T. Goodwin, H. A. Khant, W. Chiu, K. C. Li, Nanotechnology 2011, 22, 155605.